| Product Code: ETC7909760 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Drug Discovery Outsourcing Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Drug Discovery Outsourcing Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Drug Discovery Outsourcing Market - Industry Life Cycle |
3.4 Latvia Drug Discovery Outsourcing Market - Porter's Five Forces |
3.5 Latvia Drug Discovery Outsourcing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Drug Discovery Outsourcing Market Revenues & Volume Share, By Drug Molecule, 2021 & 2031F |
3.7 Latvia Drug Discovery Outsourcing Market Revenues & Volume Share, By Discovery Approach, 2021 & 2031F |
3.8 Latvia Drug Discovery Outsourcing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Latvia Drug Discovery Outsourcing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Latvia Drug Discovery Outsourcing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Latvia Drug Discovery Outsourcing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for cost-effective drug discovery solutions |
4.2.2 Growing focus on research and development activities in pharmaceutical companies |
4.2.3 Availability of skilled workforce and advanced infrastructure in Latvia |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and compliance standards |
4.3.2 Limited awareness and understanding of drug discovery outsourcing benefits in the market |
4.3.3 Competition from established outsourcing destinations |
5 Latvia Drug Discovery Outsourcing Market Trends |
6 Latvia Drug Discovery Outsourcing Market, By Types |
6.1 Latvia Drug Discovery Outsourcing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Chemical Services, 2021- 2031F |
6.1.4 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Biology Services, 2021- 2031F |
6.2 Latvia Drug Discovery Outsourcing Market, By Drug Molecule |
6.2.1 Overview and Analysis |
6.2.2 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.2.3 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Large Molecules, 2021- 2031F |
6.3 Latvia Drug Discovery Outsourcing Market, By Discovery Approach |
6.3.1 Overview and Analysis |
6.3.2 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Empirical Drug Discovery, 2021- 2031F |
6.3.3 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Rational Drug Discovery, 2021- 2031F |
6.4 Latvia Drug Discovery Outsourcing Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Target Identification and Screening, 2021- 2031F |
6.4.3 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Lead Identification and Candidate Optimization, 2021- 2031F |
6.4.4 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Development of Disease Models, 2021- 2031F |
6.4.5 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Pre-formulation Studies, 2021- 2031F |
6.4.6 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Entire Clinical Trials, 2021- 2031F |
6.4.7 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Latvia Drug Discovery Outsourcing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Anti-infective, 2021- 2031F |
6.5.3 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.5.4 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Central Nervous System, 2021- 2031F |
6.5.5 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.5.6 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Endocrine, 2021- 2031F |
6.5.7 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Gastrointestinal, 2021- 2031F |
6.5.8 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Latvia Drug Discovery Outsourcing Market, By End-user |
6.6.1 Overview and Analysis |
6.6.2 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.6.3 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F |
6.6.4 Latvia Drug Discovery Outsourcing Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
7 Latvia Drug Discovery Outsourcing Market Import-Export Trade Statistics |
7.1 Latvia Drug Discovery Outsourcing Market Export to Major Countries |
7.2 Latvia Drug Discovery Outsourcing Market Imports from Major Countries |
8 Latvia Drug Discovery Outsourcing Market Key Performance Indicators |
8.1 Number of new drug discovery projects initiated in Latvia |
8.2 Percentage increase in research funding allocated to drug discovery outsourcing |
8.3 Growth in the number of partnerships between Latvian research institutions and pharmaceutical companies |
9 Latvia Drug Discovery Outsourcing Market - Opportunity Assessment |
9.1 Latvia Drug Discovery Outsourcing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Drug Discovery Outsourcing Market Opportunity Assessment, By Drug Molecule, 2021 & 2031F |
9.3 Latvia Drug Discovery Outsourcing Market Opportunity Assessment, By Discovery Approach, 2021 & 2031F |
9.4 Latvia Drug Discovery Outsourcing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Latvia Drug Discovery Outsourcing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Latvia Drug Discovery Outsourcing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Latvia Drug Discovery Outsourcing Market - Competitive Landscape |
10.1 Latvia Drug Discovery Outsourcing Market Revenue Share, By Companies, 2024 |
10.2 Latvia Drug Discovery Outsourcing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here